DAB2IP and melanoma: Altogether, DAB2IP is robustly expressed in control tissue and retained in epithelioid melanoma, but significantly downregulated in RB, mixoid melanoma, and spindle melanoma, suggesting that loss of this tumor suppressor may accompany neoplastic progression in specific ocular malignancies.